n alternative to EpiPen is about to return to the marketplace, but with a complicated pricing strategy that may appeal to some consumers, but not necessarily to insurers.

Starting next month, Kaleo will begin selling its Auvi-Q allergic-reaction device for $360 in cash to people without insurance. But the company will cover the cost entirely for those with high-deductible insurance plans or who have a household income less than $100,000 and also lack insurance.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.